Saitama, Japan

Hiromasa Omori

This inventor holds 2 USPTO granted patents. Top assignee: Nikken Chemicals Co., Ltd.. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromasa Omori. Retrieved from https://idiyas.com/inventor/hiromasa-omori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 1.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Omiya, JP (2001)
  • Saitama, JP (2002)

Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiromasa Omori: Innovator in Pharmaceutical Chemistry

Introduction

Hiromasa Omori is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 2 patents to his name, Omori continues to push the boundaries of scientific research.

Latest Patents

Omori's latest patents include a process for the preparation of ipidacrine or ipidacrine hydrochloride hydrate. Additionally, he has developed 1,4-dihydropyridine derivatives, specifically a 1,4-dihydropyridine derivative having the formula (I). These inventions showcase his expertise in creating valuable pharmaceutical compounds.

Career Highlights

Omori is currently employed at Nikken Chemicals Co., Ltd., where he applies his knowledge and skills to advance the company's research initiatives. His work has been instrumental in the development of new therapeutic agents that can potentially improve patient outcomes.

Collaborations

Throughout his career, Omori has collaborated with esteemed colleagues such as Akira Kiue and Shigeyuki Tasaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hiromasa Omori is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His contributions, particularly in the development of ipidacrine and 1,4-dihydropyridine derivatives, highlight his commitment to innovation and excellence.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…